Evas Therapeutics, LLC

Ballwin, MO 63021

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.69MM
First Award Date 01/15/05
Most Recent Award Date 05/01/13

Key Personnel

Last Name Name Awards Contact
Wun Tze-Chein Wun 4

4 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 05/01/13 - 04/30/14

DESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthetic graft (AVG). Unfortunately, primary failure rates were as high as 60 % at 6 months after AVF creation and 77% at 1 year after AVG construction....

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 05/08/12 - 04/30/13

DESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthetic graft (AVG). Unfortunately, primary failure rates were as high as 60 % at 6 months after AVF creation and 77% at 1 year after AVG construction....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/09 - 06/30/10

DESCRIPTION (provided by applicant): Thromboembolic disorders are major causes of morbidity and mortality in the Western societies. Anticoagulants are pivotal agents in the prevention and treatment of arterial and venous thrombosis. The limitations of currently approved anticoagulant drugs have prompted the search for new anticoagulants with bet...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/15/05 - 07/14/05

DESCRIPTION (provided by applicant): Phase I: Clot formation in the blood vessel (thrombosis) causes a broad range of serious clinical conditions, such as unstable angina, acute myocardial infarction, ischemic stroke, deep vein thrombosis, pulmonary embolism, disseminated intravascular coagulation, and peripheral vascular disease. It is a leadin...